Pneumococcal disease is any infection caused by bacteria called Pneumococcus and Streptococcus pneumonia. Pneumococcus is the most common cause of pneumonia, meningitis, bloodstream infections, and middle ear infections and mostly affects people with weakened immune systems and is common in older people and children.
MARKET DYNAMICS
The Pneumococcal testing market is expected to witness robust growth owing to the advancement in POC testing products and development of advanced nucleic acid detection tests. Also, the untapped markets in the developing economies and increase in adoption of molecular diagnostic testing are expected to provide new avenues for the growth of pneumococcal testing market in the forecast period. However, the variation in effectiveness of detection tests can restrain the market growth.
MARKET SCOPE
The "Pneumococcal testing market Analysis to 2028" is a specialized and in-depth study of the Biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of pneumococcal testing market with detailed market segmentation with type and end user. The Pneumococcal testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Pneumococcal testing market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Pneumococcal testing market is segmented on the basis of method, technology and end user. On the basis of method, the pneumococcal testing market is divided into immunodiagnostics, molecular diagnostics and point of care testing. On basis of technology, the pneumococcal testing market can be segmented into enzyme-linked immunosorbent assay (Elisa), immunofluorescence, western blot, polymerase chain reaction (Pcr), immunohistochemistry (Ihc) and others. Based on end user, the market can segmented into hospitals, diagnostic laboratories, homecare and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pneumococcal testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pneumococcal testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
`The report analyzes factors affecting pneumococcal testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the pneumococcal testing market in these regions.
MARKET PLAYERS
The report covers key developments in pneumococcal testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pneumococcal testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for pneumococcal testing market in the global market. Below mentioned is the list of few companies engaged in the pneumococcal testing market.
The report also includes the profiles of key players in pneumococcal testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- F-Hoffmann la Roche Ltd.
- BioMerieux [INSTITUT MERIEUX SA]
- Hologic Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories Inc.
- DiaSorin Inc.
- Meridian Bioscience Inc.
- Quidel Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.